{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T00:14:08Z","timestamp":1715213648101},"reference-count":17,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2021]]},"DOI":"10.3960\/jslrt.20058","type":"journal-article","created":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T22:09:47Z","timestamp":1627682987000},"page":"145-151","source":"Crossref","is-referenced-by-count":0,"title":["Establishment of an ATLL cell line (YG-PLL) dependent on IL-2 and                    IL-4, which are replaced by OX40-ligand&lt;sup&gt;+&lt;\/sup&gt; HK with poly-L-histidine and                    dermatan sulfate"],"prefix":"10.3960","volume":"61","author":[{"given":"Yoshitoyo","family":"Kagami","sequence":"first","affiliation":[{"name":"Department of Hematology, Toyota Kosei                            Hospital, Toyota, Aichi, Japan,"},{"name":"Department of Hematology and Cell Therapy,                            Aichi Cancer Center Hospital, Nagoya, Aichi, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harumi","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Hematology and Cell Therapy,                            Aichi Cancer Center Hospital, Nagoya, Aichi, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutaka","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratories, Aichi                            Cancer Center Hospital, Nagoya, Aichi, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Seto","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of                            Internal Medicine, Aichi Medical University School of Medicine,                            Nagakute, Aichi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhito","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Hematology and Cell Therapy,                            Aichi Cancer Center Hospital, Nagoya, Aichi, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977; 50: 481-492.","DOI":"10.1182\/blood.V50.3.481.bloodjournal503481"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA. 1982; 79: 2031-2035.","DOI":"10.1073\/pnas.79.6.2031"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Kataoka K, Nagata Y, Kitanaka A <i>et al.<\/i> Integrated molecular analysis of adult T cell leukemia\/lymphoma. Nat Genet. 2015; 47: 1304-1315.","DOI":"10.1038\/ng.3415"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Hattori T, Uchiyama T, Toibana T, Takatsuki K, Uchino H. Surface phenotype of Japanese adult T-cell leukemia cells characterized by monoclonal antibodies. Blood. 1981; 58: 645-647.","DOI":"10.1182\/blood.V58.3.645.645"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Tsuda H, Huang RW, Takatsuki K. Interleukin-2 prevents programmed cell death in adult T-cell leukemia cells. Jpn J Cancer Res. 1993; 84: 431-437.","DOI":"10.1111\/j.1349-7006.1993.tb00154.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Arima N, Daitoku Y, Ohgaki S <i>et al.<\/i> Autocrine growth of interleukin 2-producing leukemic cells in a patient with adult T cell leukemia. Blood. 1986; 68: 779-782.","DOI":"10.1182\/blood.V68.3.779.bloodjournal683779"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Uchiyama T, Kamio M, Kodaka T <i>et al.<\/i> Leukemic cells from some adult T-cell leukemia patients proliferate in response to interleukin-4. Blood. 1988; 72: 1182-1186.","DOI":"10.1182\/blood.V72.4.1182.bloodjournal7241182"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Kagami Y, Sivasundaram K, Nakagawa A, <i>et al.<\/i> Establishment of an Adult T-Cell Leukemia Cell Line (HU-ATTAK) Dependent for Proliferation on Human Umbilical Cord Vein Endothelial Cells. The Open leukemia Journal. 2011; 4 : 1-8.","DOI":"10.2174\/1876816401104010001"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Croft M, So T, Duan W, Soroosh P. The significance of OX40 and OX40L to T-cell biology and immune disease. Immunol Rev. 2009; 229: 173-191.","DOI":"10.1111\/j.1600-065X.2009.00766.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Kunitomi A, Hori T, Maeda M, Uchiyama T. OX40 signaling renders adult T-cell leukemia cells resistant to Fas-induced apoptosis. Int J Hematol. 2002; 76: 260-266.","DOI":"10.1007\/BF02982796"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Chihara D, Kagami Y, Kato H <i>et al.<\/i> IL2\/IL-4, OX40L and FDC-like cell line support the in vitro tumor cell growth of adult T-cell leukemia\/lymphoma. Leuk Res. 2014; 38: 608-612.","DOI":"10.1016\/j.leukres.2014.03.003"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Kagami Y, Uchiyama S, Kato H <i>et al.<\/i> Establishment of cell lines from adult T-cell leukemia cells dependent on negatively charged polymers. J Clin Exp Hematop. 2017; 57: 9-14.","DOI":"10.3960\/jslrt.16021"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Kim HS, Zhang X, Klyushnenkova E, Choi YS. Stimulation of germinal center B lymphocyte proliferation by an FDC-like cell line, HK. J Immunol. 1995; 155: 1101-1109.","DOI":"10.4049\/jimmunol.155.3.1101"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Haga K, Ohno S, Yugawa T <i>et al.<\/i> Efficient immortalization of primary human cells by p16 INK4a -specific short hairpin RNA or Bmi-1, combined with introduction of hTERT. Cancer Sci. 2007; 98: 147-154.","DOI":"10.1111\/j.1349-7006.2006.00373.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Kneba M, Bolz I, Linke B <i>et al.<\/i> Characterization of clone-specific rearrangement T-cell receptor gamma- chain genes in lymphomas and leukemias by the polymerase chain reaction and DNA sequencing. Blood. 1994; 84: 574-581.","DOI":"10.1182\/blood.V84.2.574.bloodjournal842574"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Kagami Y, Jung J, Choi YS <i>et al.<\/i> Establishment of a follicular lymphoma cell line (FLK-1) dependent on follicular dendritic cell-like cell line HK. Leukemia. 2001; 15: 148-156.","DOI":"10.1038\/sj.leu.2402002"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Li L, Yoon SO, Fu DD, Zhang X, Choi YS. Novel follicular dendritic cell molecule, 8D6, collaborates with CD44 in supporting lymphomagenesis by a Burkitt lymphoma cell line, L3055. Blood. 2004; 104: 815-821.","DOI":"10.1182\/blood-2004-01-0292"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/61\/3\/61_20058\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T05:24:58Z","timestamp":1715145898000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/61\/3\/61_20058\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.20058","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"article-number":"20058"}}